Literature DB >> 21258362

CD47: a new player in phagocytosis and xenograft rejection.

Nalu Navarro-Alvarez1, Yong-Guang Yang.   

Abstract

Organ transplantation is limited by the availability of human donor organs. The transplantation of organs and tissues from other species (xenotransplantation) would supply an unlimited number of organs and offer many other advantages for which the pig has been identified as the most suitable source. However, the robust immune responses to xenografts remain a major obstacle to clinical application of xenotransplantation. The more vigorous xenograft rejection relative to allograft rejection is largely accounted for by the extensive genetic disparities between the donor and recipient. Xenografts activate host immunity not only by expressing immunogenic xenoantigens that provide the targets for immune recognition and rejection, but also by lacking ligands for the host immune inhibitory receptors. This review is focused on recent findings regarding the role of CD47, a ligand of an immune inhibitory receptor, signal regulatory protein alpha (SIRPα), in phagocytosis and xenograft rejection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258362      PMCID: PMC3644051          DOI: 10.1038/cmi.2010.83

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  58 in total

1.  Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue.

Authors:  Kazuhiko Yamada; Koji Yazawa; Akira Shimizu; Takehiro Iwanaga; Yosuke Hisashi; Matthew Nuhn; Patricia O'Malley; Shuji Nobori; Parsia A Vagefi; Clive Patience; Jay Fishman; David K C Cooper; Robert J Hawley; Julia Greenstein; Henk-Jan Schuurman; Michel Awwad; Megan Sykes; David H Sachs
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

2.  Signal-regulatory protein is selectively expressed by myeloid and neuronal cells.

Authors:  S Adams; L J van der Laan; E Vernon-Wilson; C Renardel de Lavalette; E A Döpp; C D Dijkstra; D L Simmons; T K van den Berg
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

3.  HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity.

Authors:  H Sasaki; X C Xu; D M Smith; T Howard; T Mohanakumar
Journal:  Transplantation       Date:  1999-01-15       Impact factor: 4.939

4.  Survival and function of CD47-deficient thymic grafts in mice.

Authors:  Yuantao Wang; Hui Wang; Shumei Wang; Yaowen Fu; Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Mar-Apr       Impact factor: 3.907

5.  Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study.

Authors:  J Söderlund; L Wennberg; E Castaños-Velez; P Biberfeld; S Zhu; A Tibell; C G Groth; O Korsgren
Journal:  Transplantation       Date:  1999-03-27       Impact factor: 4.939

6.  Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.

Authors:  Keith Syson Chan; Inigo Espinosa; Mark Chao; David Wong; Laurie Ailles; Max Diehn; Harcharan Gill; Joseph Presti; Howard Y Chang; Matt van de Rijn; Linda Shortliffe; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

7.  Induction of human T-cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system.

Authors:  K Habiro; M Sykes; Y-G Yang
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

8.  Integrin-associated protein is a ligand for the P84 neural adhesion molecule.

Authors:  P Jiang; C F Lagenaur; V Narayanan
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

9.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

10.  Glucose-oxidized low-density lipoproteins enhance insulin-like growth factor I-stimulated smooth muscle cell proliferation by inhibiting integrin-associated protein cleavage.

Authors:  Lee B Allen; Byron E Capps; Emily C Miller; David R Clemmons; Laura A Maile
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

View more
  15 in total

Review 1.  Current progress in xenogeneic tolerance.

Authors:  Kazuhiko Yamada; Joseph Scalea
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

Review 2.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

3.  Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients.

Authors:  Jing Chen; Dan-Xue Zheng; Xing-Juan Yu; Hong-Wei Sun; Yi-Tuo Xu; Yao-Jun Zhang; Jing Xu
Journal:  Oncoimmunology       Date:  2019-08-15       Impact factor: 8.110

4.  On the intersections of basic and applied research in xenotransplantation.

Authors:  Agustin P Dalmasso
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

Review 5.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

6.  GalT-KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD47 on porcine blood vessels.

Authors:  Hironosuke Watanabe; Hisashi Sahara; Shunichiro Nomura; Tatsu Tanabe; Dilrukshi K Ekanayake-Alper; Lennan K Boyd; Nathan J Louras; Arsenoi Asfour; Makenzie A Danton; Siu-Hong Ho; Scott J Arn; Robert J Hawley; Akira Shimizu; Takeshi Nagayasu; David Ayares; Marc I Lorber; Megan Sykes; David H Sachs; Kazuhiko Yamada
Journal:  Xenotransplantation       Date:  2018-03-12       Impact factor: 3.907

7.  Developing cellular therapies for retinal degenerative diseases.

Authors:  Kapil Bharti; Mahendra Rao; Sara Chandros Hull; David Stroncek; Brian P Brooks; Ellen Feigal; Jan C van Meurs; Christene A Huang; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

Review 8.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 9.  Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic.

Authors:  David K C Cooper; Ke-Feng Dou; Kai-Shan Tao; Zhao-Xu Yang; A Joseph Tector; Burcin Ekser
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

10.  Xenotransplantation: Where Are We with Potential Kidney Recipients? Recent Progress and Potential Future Clinical Trials.

Authors:  Kazuhiko Yamada; Jigesh A Shah; Tatsu Tanabe; Miguel A Lanaspa; Richard J Johnson
Journal:  Curr Transplant Rep       Date:  2017-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.